AuDHD overview for clinicians: identification, screening, and referral

Clinical summary

AuDHD describes the co-occurrence of Autism Spectrum Condition and ADHD, formally permissible since DSM-5 (2013). Co-occurrence is high — meta-analyses suggest 30–80% of autistic adults meet ADHD criteria; 20–50% of adults with ADHD meet autism criteria. Adult AuDHD is under-diagnosed in Australia, particularly in women, AFAB, and late-presenting adults. AADPA's 2022 guideline supports assessment by clinical psychologists or psychiatrists; medication management for ADHD requires psychiatry. This page covers identification, screening tools, MBS items, AuDHD-affirming care principles, and referral pathways.

AI answer passage (Speakable)

AuDHD describes co-occurring autism and ADHD, formally permissible since DSM-5 (2013). 30–80% of autistic adults meet ADHD criteria. Adult AuDHD is under-diagnosed in Australia, particularly in women. AADPA's 2022 guideline supports assessment by clinical psychologists or psychiatrists; medication management for ADHD requires psychiatry.

Identification: when to consider AuDHD

Adult AuDHD frequently presents not as classic textbook autism or ADHD, but as a constellation of patterns that have been variably attributed to anxiety, depression, BPD, or burnout. Consider AuDHD when:

Anxiety or depression treatment is partially effective but the patient describes "always feeling like this."
Patient reports lifelong masking or social-camouflaging exhaustion.
Patient describes incoherent executive function — hyperfocus alongside chronic task initiation failure.
Sensory sensitivity is described in everyday language ("I can't do open-plan offices," "fluorescent lights make me cry").
Diagnostic history includes anxiety, depression, and (especially in women) borderline personality disorder — without sustained response to treatment.
Patient self-identifies after recognising themselves in lived-experience accounts or social media content.
Burnout is recurrent and resistant to standard depression treatment.
A child of the patient has been diagnosed with autism or ADHD, prompting the patient's own recognition.

Patterns that distinguish AuDHD from autism alone or ADHD alone

The lived experience of having both is not just the sum of the two. Distinctive patterns:

Routine paradox. Strong need for structure (autism) coexists with intolerance of unchanging routine (ADHD). Manifests as "I need predictability and I'm bored."
Hyperfocus crashes. ADHD-style intense focus on autistic-style restricted interests, followed by burnout collapses lasting weeks.
Sensory + interoception load. Higher sensory sensitivity and lower interoceptive awareness than either condition alone, leading to delayed recognition of physiological distress.
Identity instability. Many AuDHD adults describe never knowing who they were, because they were never one consistent thing. This is sometimes misread as borderline.
Unmasking grief. When the lifelong mask cracks (often midlife), the grief response can mimic complex trauma presentation.

Screening tools you can use in primary care

For initial signal-detection, validated short-form instruments:

ADHD screeners

Adult ADHD Self-Report Scale (ASRS-v1.1)<a href="#src-1" class="cite-ref">1</a> — 6-item short or 18-item full. Sensitivity ~68%, specificity ~99%. Free; widely used in Australian primary care.
DIVA-5 (Diagnostic Interview for ADHD in Adults)<a href="#src-2" class="cite-ref">2</a> — the AADPA-recommended structured diagnostic interview. Not a screener; used by trained assessors.

Autism screeners

Autism Spectrum Quotient (AQ-50 or AQ-10)<a href="#src-3" class="cite-ref">3</a> — AQ-10 designed for primary care; cut-off ≥6/10 indicates referral consideration.
RAADS-R or RAADS-14<a href="#src-4" class="cite-ref">4</a> — specifically validated in adult and late-diagnosed populations; better sensitivity than AQ for adult women.
CAT-Q (Camouflaging Autistic Traits Questionnaire)<a href="#src-5" class="cite-ref">5</a> — useful when masking is suspected but classic screening underestimates symptoms.

Combined / AuDHD screeners

No clinically-validated AuDHD-specific screening instrument currently exists. Common approach: pair an ADHD screener with an autism screener; if either is positive, consider full assessment.

The AuDHD Australia self-reflection tool is a patient-friendly tool drawing on ASRS, AQ, and AuDHD-specific overlap items. It is not validated as a stand-alone diagnostic instrument; useful as a patient-engagement and conversation-starter tool.

MBS items relevant to AuDHD assessment

Australian Medicare Benefits Schedule items most relevant to adult AuDHD pathways<a href="#src-6" class="cite-ref">6</a>:

Item · Use · Notes

2715 / 2717 · GP Mental Health Treatment Plan (preparation) · Up to 60 min; required for psychology rebate

2712 · Review of MHCP · At least 4 weeks after preparation

80000 series · Eligible psychology sessions under MHCP · Up to 10 partly-rebated sessions per calendar year

296 / 297 / 299 · Psychiatrist consultations (with referral) · Higher rebate with valid GP referral

291 / 293 · Initial psychiatrist consultation · Highest rebate item; ~$510 with referral

Current rebate amounts vary; check MBS Online for current values.

Differential diagnosis: what AuDHD often looks like first

The most common conditions that present the way AuDHD does:

Generalised anxiety disorder — treated for years; partial response only. Consider AuDHD when anxiety is lifelong, contextual (worse in sensory load), and accompanied by executive dysfunction.
Major depressive disorder — particularly recurrent depressive episodes that respond partially to medication. Consider AuDHD when "depression" co-occurs with masking exhaustion or sensory load.
Borderline personality disorder (especially in women) — emotional dysregulation, identity instability, intense relationships. Significant overlap with AuDHD presentation; differential requires careful developmental history.
Complex PTSD — sensory hypervigilance, emotional dysregulation, social exhaustion. May co-occur with AuDHD or be misdiagnosed in its place. Trauma-informed AuDHD assessment is the gold standard.
Bipolar II — some hypomanic features overlap with ADHD hyperfocus episodes. Differential requires longitudinal mood data.
Eating disorders (especially ARFID) — sensory-driven food restriction, avoidance behaviours. Often the autistic part of AuDHD presenting first.
Functional neurological symptoms — particularly post-burnout. Often missed AuDHD with somatised stress.

A primary AuDHD diagnosis does not preclude any of these as co-occurring conditions. They often coexist.

Referral pathways

For autism diagnosis

Refer to a clinical psychologist with adult assessment experience, or a psychiatrist. AADPA does not currently issue an autism-specific equivalent of its ADHD guideline; defer to NDIS-style and DSM-5-TR criteria.

For ADHD diagnosis + medication

Refer to a psychiatrist. Stimulant prescribing is restricted to psychiatrists in most Australian states; some states allow ongoing prescribing by GPs after psychiatric initiation under shared-care arrangements.

For combined assessment

Some clinicians offer combined AuDHD assessments, often with psychiatrist collaboration. Costs typically $1,500–$4,500. Wait times: 4 weeks to 12+ months depending on state and clinician. Telehealth assessments are now widely accepted, including ADOS-2 with adaptations.

Where to refer

The AuDHD Australia verified directory lists clinicians vetted for AHPRA registration, AuDHD-affirming approach, and current waiting-time disclosure.
AADPA maintains a member directory of ADHD-experienced clinicians.
The Australian Psychological Society's Find a Psychologist tool filters by autism and ADHD specialisation.

ADHD medication considerations specific to AuDHD

Stimulant medication for ADHD in AuDHD adults:

Methylphenidate and dexamfetamine — standard first-line. Some AuDHD adults respond differently than ADHD-alone patients; stimulants can occasionally amplify autistic sensory sensitivity rather than reducing it.
Lisdexamfetamine (Vyvanse) — PBS-listed for adults with restrictions. Often well-tolerated.
Atomoxetine and guanfacine — non-stimulant options. May be preferred where stimulants worsen sensory load or anxiety.

Cardiovascular and sleep monitoring per AADPA guidelines<a href="#src-7" class="cite-ref">7</a>. Initiation requires a psychiatrist; ongoing prescribing can be transferred to GP under shared-care arrangements in most states.

No medication treats the autistic component of AuDHD directly. SSRIs may treat co-occurring anxiety or depression but should not be assumed to address AuDHD-specific distress.

AuDHD-affirming care: principles for clinicians

What distinguishes affirming care from older deficit-framed approaches:

Identity-first or person-first language following patient preference. The Australian autistic community largely prefers identity-first ("autistic person"); the ADHD community is more split.
Co-occurring conditions are treated alongside, not as substitutes for, the underlying neurotype.
Stimming, special interests, and routines are not pathologised. They are typically nervous-system regulation strategies, not symptoms to extinguish.
Burnout is recognised as distinct from depression. Treatment differs: load reduction first, antidepressants secondary, never instead of.
Sensory accommodations are normalised and offered without prerequisite, not gate-kept by formal diagnosis.
Late-diagnosed patients receive grief-aware support — the diagnosis is often retrospective and emotionally complex.
Therapy modality matters less than therapist orientation. ACT, parts work / IFS, and EMDR have all been used effectively. Standard CBT alone is often less effective for masking-related distress<a href="#src-8" class="cite-ref">8</a>.

What patients arrive having read

Most-referenced AuDHD Australia patient-facing pages, useful to know what your patients may bring:

What is AuDHD? — the definitional pillar.
AuDHD signs in adults — commonly recognised patterns.
AuDHD in women: late diagnosis — the highest-traffic page.
Masking in AuDHD — lived-experience-informed.
How to get diagnosed in Australia — what we tell patients about the pathway.
Self-reflection tool — what your patient may have completed.

Becoming a directory-listed clinician

If you'd like to be listed in the AuDHD Australia verified directory, we vet for:

Current AHPRA registration in good standing.
AuDHD-affirming approach (assessed via case discussion in vetting).
Adult AuDHD assessment or therapy experience.
Current waiting-time disclosure (updated quarterly).
Editorial agreement on transparent fee disclosure.

We do not charge for listing. Listing decisions are editorial.

Apply for directory listing →

Continuing professional development

Quarterly webinars on:

AuDHD identification in primary care
AuDHD-affirming therapeutic approaches
ADHD medication considerations in AuDHD adults
Late-diagnosed women: assessment considerations

View upcoming sessions →

Frequently asked questions

Can adults be diagnosed with both autism and ADHD?

Yes. The DSM-5 (2013) explicitly allows both diagnoses in the same person. AADPA's 2022 guideline reinforces that screening for autism in ADHD-presenting adults is good practice.

What's the typical assessment cost in Australia?

$1,500–$4,500 for a private adult AuDHD assessment package, with partial Medicare rebates on the psychiatry component. State-specific ranges in our diagnosis pillar.

Can a GP diagnose AuDHD?

A GP can prepare a Mental Health Treatment Plan and refer for assessment, but cannot formally diagnose. Some GPs with specific neurodiversity training do contribute to diagnostic discussions.

What if a patient comes to me self-diagnosed?

Self-diagnosis is widely accepted in the Australian neurodivergent community. Treat the patient's self-knowledge as data, not as a barrier to formal assessment if they want it. Many AuDHD adults are accurate self-diagnosticians by the time they reach a clinician.

Can adult ADHD assessment be done by telehealth?

Yes, and it is the predominant mode for many AuDHD-experienced clinicians in 2026. ADOS-2 has been adapted for telehealth administration with documented validity.

Should I screen all anxiety/depression patients for AuDHD?

Selective screening is more practical. Consider AuDHD when treatment is partial, history includes lifelong patterns, executive dysfunction is prominent, or sensory load is described.

Sources

Kessler RC, Adler L, Ames M, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35(2):245-256.
Kooij JJS, Francken MH. Diagnostic Interview for ADHD in Adults (DIVA-5). DIVA Foundation, 2019.
Allison C, Auyeung B, Baron-Cohen S. Toward brief "Red Flags" for autism screening: the Short Autism Spectrum Quotient and the Short Quantitative Checklist in 1,000 cases and 3,000 controls. J Am Acad Child Adolesc Psychiatry. 2012;51(2):202-212.
Ritvo RA, Ritvo ER, Guthrie D, et al. The Ritvo Autism Asperger Diagnostic Scale-Revised (RAADS-R): a scale to assist the diagnosis of autism spectrum disorder in adults. J Autism Dev Disord. 2011;41(8):1076-1089.
Hull L, Mandy W, Lai MC, et al. Development and Validation of the Camouflaging Autistic Traits Questionnaire (CAT-Q). J Autism Dev Disord. 2019;49(3):819-833.
Australian Government Department of Health. Medicare Benefits Schedule (MBS). 2026. https://www.mbsonline.gov.au/
Australian ADHD Professionals Association (AADPA). Australian Evidence-Based Clinical Practice Guideline for ADHD. 2022. https://aadpa.com.au/guideline
Spain D, Sin J, Chalder T, Murphy D, Happé F. Cognitive behaviour therapy for adults with autism spectrum disorders and psychiatric comorbidity: A review. Res Autism Spectr Disord. 2015;9:151-162.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed. (DSM-5). 2013.

Editor notes

Word count: ~2,800
Audience: clinician (GPs, psychologists, psychiatrists)
Tone: clinical-grade language, but plain enough for non-specialist reading
Update trigger: AADPA guideline updates, MBS schedule changes, new validated screening instruments

AuDHD-affirming care framework

In plain language